Skip to main content
. 2011 Nov 17;52(11):776–781. doi: 10.4111/kju.2011.52.11.776

FIG. 1.

FIG. 1

(A) Treatment outcomes according to frequency (p=0.044). (B) N-Acetyl-β-d-glucosaminidase (NAG)/creatinine (Cr) levels according to pretreatment (p=0.406). I: 60 shocks/min (group I), II: 120 shocks/min (group II), III: pretreatment (group III), IV: non-pretreatment (group IV).